Foot and Mouth Disease Vaccine Market, By Vaccine Type (Conventional Vaccine, Aluminum Hydroxide based vaccine, Oil based vaccines, and Emergency Vaccines), By Animal Type (Cattle, Sheep, Goat, Swine, and Others) and By Region (North America, Europe, , Asia Pacific, Latin America, Middle East and Africa) - Trends, Analysis and Forecast till 2030

Foot and mouth disease is a highly contagious viral disease occurred in animals which is caused by viral strain aphetovirus of the family picornaviridae. This type of disease occurs in animals such as cattle, swine, sheep, and goats. In wildlife, all species of deer and antelope are susceptible to foot and mouth disease where some of them, also act as a carrier of the virus without showing clinical symptoms. In a susceptible non-vaccinated population morbidity could be as high as 100% for foot and mouth disease. Foot and mouth disease is rarely fatal in adult animals but mortality can be high in young animals. Vaccination is used a protective measure in controlling FMD; however, they do not necessarily prevent animals from being infected. Vaccine are still used in various countries to control endemic situation. Moreover, complete eradicate the FMD virus through complementary control measures such as cleaning and disinfection are essential to eradicate disease. The Global Foot and Mouth Disease Vaccine Market accounted for US$ 1.96 billion in 2020 and is estimated to be US$ 4.04 billion by 2030 and is anticipated to register a CAGR of 7.50%.

Increasing prevalence of foot and mouth disease

Increasing prevalence of foot and mouth disease in animals and rising population of animal livestock across the globe are major factors driving growth of the global foot and mouth disease vaccine market. In addition, repetitive outbreak of foot and mouth disease in animals across the globe that negatively affects economy is another factor augmenting growth of the global foot and mouth disease vaccine market.

Increasing support from regulatory bodies

Furthermore, increasing approval support from regulatory bodies for novel foot and mouth disease vaccines supports the growth of the global foot and mouth disease vaccine market. For instance, in 2017, according to data published by National Center for Biotechnology Information, the Foot and Drug Administration (FDA) of China approved the first vaccine against EV71, made at the Chinese Academy of Medical Sciences by the Institute of Medical Biology. Also, in 2016, the Chinese FDA approved a second EV71 vaccine made by Sinovac Biotech and with this also approved inactivated whole EV71 vaccines in commercial production. Moreover, various initiatives undertaken by the government to mandate safe healthcare practices for livestock and companion animals is expected to boost demand for veterinary vaccines over the forecast period. This factor expected to promote growth of the global foot and mouth disease vaccine market in near future.

However, high cost associated with these vaccines is major factor expected to hamper growth of the global foot and mouth disease vaccine market over the forecast period.

The global foot and mouth disease vaccine market has been segmented on the basis of vaccine type, animal type, and region.

The vaccine type segment includes conventional vaccine, aluminum hydroxide based vaccine, oil based vaccines, and emergency vaccines. Further, global foot and mouth disease vaccine market is segmented by animal type, which includes cattle, sheep, goat, swine, and others.

On the basis of region, target market has been segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. Asia Pacific, Africa, Middle East, and Latin America were reported to accounts for higher incidence rate, which are further expected to account for major market share as compared to other regions during the fiscal year 2018.

Regional Insights:

For detailed understanding of market dynamics, the global foot and mouth disease vaccine market is analyzed across key regions viz North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Each of these regions is analyzed on the basis of market findings across major countries in these regions for a macro-level understanding of the global market. In 2018, the Asia Pacific foot and mouth disease vaccine market is expected to dominate in the global market over the forecast period. This is attributed to increasing headcount of animals in the countries of this region. Middle East and Africa market is expected to hold second largest revenue share in global foot and mouth disease vaccine market. This is owing to increasing prevalence of foot and mouth disease in this region. Latin America market is expected to show significant growth over the forecast period due to increasing incident of foot and mouth disease in the countries of the region.

Detailed Segmentation:

Global Foot and Mouth Disease Vaccine Market, By Vaccine Type:

• • • Conventional vaccine 
• • • Aluminum hydroxide based vaccine
    • Oil based vaccines 
• • • Emergency vaccines

Global Foot and Mouth Disease Vaccine Market, By Animal Type:

• • • Cattle
    • Sheep
    • Goat
    • Swine
    • Others

Global Foot and Mouth Disease Vaccine Market, By Region:

• • • North America
      • North America Foot and Mouth Disease Vaccine Market, By Vaccine Type
      • North America Foot and Mouth Disease Vaccine Market, By Animal Type
      • North America Foot and Mouth Disease Vaccine Market, By Country
        • U.S.
        • Canada
    • Europe
      • Europe Foot and Mouth Disease Vaccine Market, By Vaccine Type
      • Europe Foot and Mouth Disease Vaccine Market, By Animal Type
      • Europe Foot and Mouth Disease Vaccine Market, By Country
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Asia Pacific Foot and Mouth Disease Vaccine Market, By Vaccine Type
      • Asia Pacific Foot and Mouth Disease Vaccine Market, By Animal Type
      • Asia Pacific Foot and Mouth Disease Vaccine Market, By Country
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Latin America Foot and Mouth Disease Vaccine Market, By Vaccine Type
      • Latin America Foot and Mouth Disease Vaccine Market, By Animal Type
      • Latin America Foot and Mouth Disease Vaccine Market, By Country
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Middle East & Africa Foot and Mouth Disease Vaccine Market, By Vaccine Type
      • Middle East & Africa Foot and Mouth Disease Vaccine Market, By Animal Type
      • Middle East & Africa Foot and Mouth Disease Vaccine Market, By Country
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa

Some of the prominent players operating in the global foot and mouth disease vaccine market Indian Immunologicals Ltd., Godrej Agrovet Ltd., MSD Animal Health Srl., Vallee S.A., Bayer HealthCare LLC, Brilliant Bio Pharma Ltd., Intervet Inc., Biovet Inc., Merial Inc., China Animal Husbandry Co., Ltd., Biogenesis Bago S.A., and Vecol S.A. Advancements in the product as well as in manufacturing process, product launches, and strategic partnerships are some trends witnessed in the global foot and mouth disease vaccine market. For instance, in 2017, MSD Animal Health Srl had declared it has effectively acquired a controlling interest in Vallee S.A. which is a leading privately-held producer of animal health products.

• • • Indian Immunologicals Ltd
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance

• • • Godrej Agrovet Ltd
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance

• • • MSD Animal Health Srl
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance

• • • Vallee S.A.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance

• • • Bayer HealthCare LLC
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance

• • • Brilliant Bio Pharma Ltd.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance

• • • Intervet Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance

• • • Biovet Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance

• • • Merial Inc.
      • Company Overview
      • Product Portfolio
• • • • Key Highlights
      • Financial Performance 
      •  
    • China Animal Husbandry Co., Ltd.
      • Company Overview
• • • • Product Portfolio
      • Key Highlights
      • Financial Performance
      •  
    • Biogenesis-Bago S.A.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance

• • • Vetal Animal Health Products S.A.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance

• • • VETAL Animal Health Products
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance

• • • Vecol S.A.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance